I am a urologic surgeon who specializes in surgery for men and women with cancers of the genitourinary system. Examples of the specific tumors that I treat include cancers of the bladder, prostate, and kidney. My main areas of expertise include radical surgical procedures for invasive bladder cancer and reconstructive surgery of the urinary system following radical cystectomy or pelvic exenteration. Removal of the bladder, also called radical cystectomy, serves as the standard for definitive treatment of high-risk bladder tumors and can provide a cure in the majority of patients with early, invasive lesions. Function-sparing procedures (including preservation of the nerves responsible for erectile function and advanced reconstructive techniques that re-create the natural urination pathway after bladder removal) are also performed to provide an excellent postoperative quality of life.
I am also actively involved in clinical research to determine which treatments are most likely to maximize individual patients' chances of a cure. I have served as the lead investigator for an international effort to develop an outcomes nomogram, which provides a tool to more accurately estimate a patient's risk for recurrence after treatment for bladder cancer. This tool will provide patients and doctors with better information regarding the need for subsequent treatment (i.e., chemotherapy) following surgery. I am also the principal investigator of other studies evaluating how improved surgical quality or advanced diagnostic imaging may help us in the management of genitourinary tumors.
I joined the MSKCC staff in 2000 in the Department of Urology and currently hold the position of Associate Attending Surgeon. I serve as the coordinator of the bladder cancer multi-disciplinary working group and am co-Director of the Pelvic Reconstruction/Surgery Group at MSKCC. I am actively involved in urologic oncology at the national level, serving as faculty for post-graduate courses in urologic oncology for the American Urological Association. I also serve on the program organizing committee within the Society of Urologic Oncology, and editorial boards for urology-related journals. Additionally I am a reviewer for several peer-reviewed cancer and urology journals.
Experience / Training
Specialty:
Oncology
A self-designated specialty or practice area is not equivalent to, nor does it imply, ABMS Board Certification or special training and competence.
Medical School:
University of California at Los Angeles Los Angeles, CA
Residency:
University of Southern California (USC) School of Medicine
Fellowship:
USC/Norris Comprehensive Cancer Center
Disciplinary Actions
HealthGrades has examined disciplinary actions within the last five years from the Office of Inspector General and 50 state medical boards.
HealthGrades could not detect any disciplinary actions for Dr. Bernard H. Bochner, MD
as of 12/09/2009. Note: HealthGrades reports on state and federal disciplinary actions (if any) from the previous five years.
Malpractice History
HealthGrades did not find any closed malpractice claims for
Dr. Bernard H.
Bochner, MD
in the states of California, Connecticut, Florida, Georgia, Idaho, Indiana, Massachusetts, Maryland, North Dakota, New Jersey, New York, Oregon, Tennessee, Texas, Virginia, Vermont, or West Virginia.
Learn More
Note: HealthGrades obtains physician information from a variety of sources. Some information that is not designated as HealthGrades verified has been reported by the physician.
We comply with the HONcode standard for trustworthy health information. Verify here.
